People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neuropathix, Inc. | — | Pharmaceuticals | Series C | $51.3M | $271.0M | 2021 |
| KannaLife Sciences, Inc. | — | Pharmaceuticals | Series A | $16.5M | $57.1M | 2013 |
| Full Motion Beverage, Inc. | — | Other | Series A | $5.0M | $12.5M | — |
Dean Petkanas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dean Petkanas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Corrao | 2 | 6 |
| Robert Malasek | 1 | 2 |
| Timothy Scott | 1 | 2 |
| Stuart Titus | 1 | 2 |
| Michael Mona, Jr. | 1 | 2 |
| Dead Petkanas | 1 | 1 |
| W. Dennis Drehkoff | 1 | 1 |
| Thomas Dennis Kikis | 1 | 1 |
| Ramesh Dennis Pandey | 1 | 1 |
| Thoma Kikis | 1 | 1 |
| William Kinney | 1 | 1 |
| Blake Schroeder | 1 | 1 |
| Thomas Kikis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.